{"transactions":[{"id":1125182,"issuer":{"id":37706,"kind":"organization","name":"Assertio Holdings, Inc.","symbol":"ASRT"},"owners":[{"id":27437,"kind":"person","name":"O'Grady Brendan P.","position":1,"cik":"0001726533","reported_name":"O'Grady Brendan P.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Restricted Stock Units","published_at":"2025-06-03T22:00:13.000Z","date":"2025-05-31","kind":"exercise","planned":false,"acquired":false,"shares":166665,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the registrant's common stock."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The derivative securities were granted to the reporting person, and were not sold to the reporting person. As such, the reporting person did not pay any consideration for the derivative securities."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"One-third of these restricted stock units vests on each of May 31, 2025, 2026 and 2027, assuming continued employment through the applicable vesting date."}],"balance_after":333335,"derivative":{"exercise_price":0,"expiration_date":"2027-05-31","underlying":"Common Stock","underlying_shares":166665},"source":{"system":"sec-edgar","filing":"0001104659-25-056049","document":"tm2516886-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1808665/000110465925056049/tm2516886-1_4seq1.xml","form_type":"4"}},{"id":1125181,"issuer":{"id":37706,"kind":"organization","name":"Assertio Holdings, Inc.","symbol":"ASRT"},"owners":[{"id":27437,"kind":"person","name":"O'Grady Brendan P.","position":1,"cik":"0001726533","reported_name":"O'Grady Brendan P.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2025-06-03T22:00:13.000Z","date":"2025-05-31","kind":"tax_withholding","planned":false,"acquired":false,"shares":49416,"price":0.6643,"value":32827.0488,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock withheld for payment of taxes upon the vesting of restricted stock units."}],"balance_after":128955.462,"source":{"system":"sec-edgar","filing":"0001104659-25-056049","document":"tm2516886-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1808665/000110465925056049/tm2516886-1_4seq1.xml","form_type":"4"}},{"id":1125180,"issuer":{"id":37706,"kind":"organization","name":"Assertio Holdings, Inc.","symbol":"ASRT"},"owners":[{"id":27437,"kind":"person","name":"O'Grady Brendan P.","position":1,"cik":"0001726533","reported_name":"O'Grady Brendan P.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2025-06-03T22:00:13.000Z","date":"2025-05-31","kind":"exercise","planned":false,"acquired":true,"shares":166665,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":178371.462,"source":{"system":"sec-edgar","filing":"0001104659-25-056049","document":"tm2516886-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1808665/000110465925056049/tm2516886-1_4seq1.xml","form_type":"4"}},{"id":1255964,"issuer":{"id":37706,"kind":"organization","name":"Assertio Holdings, Inc.","symbol":"ASRT"},"owners":[{"id":27437,"kind":"person","name":"O'Grady Brendan P.","position":1,"cik":"0001726533","reported_name":"O'Grady Brendan P.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-02-20T23:00:14.000Z","date":"2025-02-18","kind":"grant","planned":false,"acquired":true,"shares":755525,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The derivative securities were granted to the reporting person, and were not sold to the reporting person. As such, the reporting person did not pay any consideration for the derivative securities."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"One-third of these restricted stock units and stock options are scheduled to vest on each of the first three anniversaries of the grant date, assuming continued employment through the applicable vesting date."}],"balance_after":755525,"derivative":{"exercise_price":0.81,"expiration_date":"2035-02-18","underlying":"Common Stock","underlying_shares":755525},"source":{"system":"sec-edgar","filing":"0001104659-25-015756","document":"tm257086-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1808665/000110465925015756/tm257086-1_4seq1.xml","form_type":"4"}},{"id":1255963,"issuer":{"id":37706,"kind":"organization","name":"Assertio Holdings, Inc.","symbol":"ASRT"},"owners":[{"id":27437,"kind":"person","name":"O'Grady Brendan P.","position":1,"cik":"0001726533","reported_name":"O'Grady Brendan P.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Restricted Stock Units","published_at":"2025-02-20T23:00:14.000Z","date":"2025-02-18","kind":"grant","planned":false,"acquired":true,"shares":500000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the registrant's common stock."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The derivative securities were granted to the reporting person, and were not sold to the reporting person. As such, the reporting person did not pay any consideration for the derivative securities."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"One-third of these restricted stock units and stock options are scheduled to vest on each of the first three anniversaries of the grant date, assuming continued employment through the applicable vesting date."}],"balance_after":500000,"derivative":{"exercise_price":0,"expiration_date":"2028-02-18","underlying":"Common Stock","underlying_shares":500000},"source":{"system":"sec-edgar","filing":"0001104659-25-015756","document":"tm257086-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1808665/000110465925015756/tm257086-1_4seq1.xml","form_type":"4"}},{"id":1363877,"issuer":{"id":37706,"kind":"organization","name":"Assertio Holdings, Inc.","symbol":"ASRT"},"owners":[{"id":27437,"kind":"person","name":"O'Grady Brendan P.","position":1,"cik":"0001726533","reported_name":"O'Grady Brendan P.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2024-11-15T19:43:25.000Z","date":"2024-11-14","kind":"purchase","planned":false,"acquired":true,"shares":11706.462,"price":0.85,"value":9950.4927,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported is a weighted average purchase price. The shares were purchased in multiple same-way transactions on November 14, 2024 at prices ranging from $0.84 to $0.85 per share of common stock. If requested by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, the reporting person will provide full information regarding the number of shares of common stock purchased at each separate price."}],"balance_after":11706.462,"source":{"system":"sec-edgar","filing":"0001104659-24-119663","document":"tm2428579-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1808665/000110465924119663/tm2428579-1_4seq1.xml","form_type":"4"}},{"id":1492569,"issuer":{"id":37706,"kind":"organization","name":"Assertio Holdings, Inc.","symbol":"ASRT"},"owners":[{"id":27437,"kind":"person","name":"O'Grady Brendan P.","position":1,"cik":"0001726533","reported_name":"O'Grady Brendan P.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-04T22:01:40.000Z","date":"2024-05-31","kind":"grant","planned":false,"acquired":true,"shares":1800000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The derivative securities were granted to the reporting person, and were not sold to the reporting person. As such, the reporting person did not pay any consideration for the derivative securities."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"One-third of these restricted stock units and stock options are scheduled to vest on each of the first three anniversaries of the grant date, assuming continued employment through the applicable vesting date."}],"balance_after":1800000,"derivative":{"exercise_price":0.99,"expiration_date":"2034-05-31","underlying":"Common Stock","underlying_shares":1800000},"source":{"system":"sec-edgar","filing":"0001104659-24-068356","document":"tm2416400-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1808665/000110465924068356/tm2416400-2_4seq1.xml","form_type":"4"}},{"id":1492568,"issuer":{"id":37706,"kind":"organization","name":"Assertio Holdings, Inc.","symbol":"ASRT"},"owners":[{"id":27437,"kind":"person","name":"O'Grady Brendan P.","position":1,"cik":"0001726533","reported_name":"O'Grady Brendan P.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Restricted Stock Units","published_at":"2024-06-04T22:01:40.000Z","date":"2024-05-31","kind":"grant","planned":false,"acquired":true,"shares":500000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the registrant's common stock."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The derivative securities were granted to the reporting person, and were not sold to the reporting person. As such, the reporting person did not pay any consideration for the derivative securities."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"One-third of these restricted stock units and stock options are scheduled to vest on each of the first three anniversaries of the grant date, assuming continued employment through the applicable vesting date."}],"balance_after":500000,"derivative":{"exercise_price":0,"expiration_date":"2027-05-31","underlying":"Common Stock","underlying_shares":500000},"source":{"system":"sec-edgar","filing":"0001104659-24-068356","document":"tm2416400-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1808665/000110465924068356/tm2416400-2_4seq1.xml","form_type":"4"}},{"id":2804329,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":27437,"kind":"person","name":"O'Grady Brendan P.","position":1,"cik":"0001726533","reported_name":"O'Grady Brendan P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, North America Commercial"}}],"security":"Restricted Share Units","published_at":"2021-03-08T21:09:52.000Z","date":"2021-03-05","kind":"grant","acquired":true,"shares":109315,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"Restricted share units were granted on March 5, 2021, with 27,328 vesting on each of March 5, 2022, March 5, 2023, March 5, 2024 and 27,331 vesting on March 5, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F8","text":"Restricted share units were granted on March 5, 2021, with 27,328 vesting on each of March 5, 2022, March 5, 2023, March 5, 2024 and 27,331 vesting on March 5, 2025."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":109315,"derivative":{"underlying":"Ordinary Shares","underlying_shares":109315},"source":{"system":"sec-edgar","filing":"0001209191-21-018526","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919121018526/doc4.xml","form_type":"4"}},{"id":2804328,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":27437,"kind":"person","name":"O'Grady Brendan P.","position":1,"cik":"0001726533","reported_name":"O'Grady Brendan P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, North America Commercial"}}],"security":"Restricted Share Units","published_at":"2021-03-08T21:09:52.000Z","date":"2021-03-04","kind":"exercise","acquired":false,"shares":18905,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"Restricted share units were granted on March 4, 2019, with 18,905 vesting on each of March 4, 2021 and March 4, 2022 and 18,906 vesting on March 4, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"Restricted share units were granted on March 4, 2019, with 18,905 vesting on each of March 4, 2021 and March 4, 2022 and 18,906 vesting on March 4, 2023."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":37811,"derivative":{"underlying":"Ordinary Shares","underlying_shares":18905},"source":{"system":"sec-edgar","filing":"0001209191-21-018526","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919121018526/doc4.xml","form_type":"4"}},{"id":2804327,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":27437,"kind":"person","name":"O'Grady Brendan P.","position":1,"cik":"0001726533","reported_name":"O'Grady Brendan P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, North America Commercial"}}],"security":"Ordinary Shares","published_at":"2021-03-08T21:09:52.000Z","date":"2021-03-05","kind":"sale","acquired":false,"shares":11436,"price":10.5439,"value":120580.0404,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.5000 to $10.5775, inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":14868.486,"source":{"system":"sec-edgar","filing":"0001209191-21-018526","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919121018526/doc4.xml","form_type":"4"}},{"id":2804326,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":27437,"kind":"person","name":"O'Grady Brendan P.","position":1,"cik":"0001726533","reported_name":"O'Grady Brendan P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, North America Commercial"}}],"security":"Ordinary Shares","published_at":"2021-03-08T21:09:52.000Z","date":"2021-03-04","kind":"sale","acquired":false,"shares":7469,"price":10.5661,"value":78918.2009,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"shares","element":"transactionShares","label":"F4","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the restricted share units listed in Table II."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.5100 to $10.6900, inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":26304.486,"source":{"system":"sec-edgar","filing":"0001209191-21-018526","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919121018526/doc4.xml","form_type":"4"}},{"id":2804325,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":27437,"kind":"person","name":"O'Grady Brendan P.","position":1,"cik":"0001726533","reported_name":"O'Grady Brendan P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, North America Commercial"}}],"security":"Ordinary Shares","published_at":"2021-03-08T21:09:52.000Z","date":"2021-03-04","kind":"exercise","acquired":true,"shares":18905,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."}],"balance_after":33773.486,"source":{"system":"sec-edgar","filing":"0001209191-21-018526","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919121018526/doc4.xml","form_type":"4"}},{"id":2804324,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":27437,"kind":"person","name":"O'Grady Brendan P.","position":1,"cik":"0001726533","reported_name":"O'Grady Brendan P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, North America Commercial"}}],"security":"Ordinary Shares","published_at":"2021-03-08T21:09:52.000Z","date":"2021-03-04","kind":"sale","acquired":false,"shares":703,"price":10.8,"value":7592.4,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."}],"balance_after":14868.486,"source":{"system":"sec-edgar","filing":"0001209191-21-018526","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919121018526/doc4.xml","form_type":"4"}},{"id":2810204,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":27437,"kind":"person","name":"O'Grady Brendan P.","position":1,"cik":"0001726533","reported_name":"O'Grady Brendan P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, North America Commercial"}}],"security":"Restricted Share Units","published_at":"2021-03-04T21:05:08.000Z","date":"2021-03-03","kind":"exercise","acquired":false,"shares":1166,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"Restricted share units were granted on March 3, 2017, with 1,166 vesting on each of March 3, 2018, March 3, 2019, March 3, 2020 and March 3, 2021."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"Restricted share units were granted on March 3, 2017, with 1,166 vesting on each of March 3, 2018, March 3, 2019, March 3, 2020 and March 3, 2021."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":0,"derivative":{"underlying":"Ordinary Shares","underlying_shares":1166},"source":{"system":"sec-edgar","filing":"0001209191-21-017764","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919121017764/doc4.xml","form_type":"4"}},{"id":2810203,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":27437,"kind":"person","name":"O'Grady Brendan P.","position":1,"cik":"0001726533","reported_name":"O'Grady Brendan P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, North America Commercial"}}],"security":"Ordinary Shares","published_at":"2021-03-04T21:05:08.000Z","date":"2021-03-03","kind":"sale","acquired":false,"shares":463,"price":10.8626,"value":5029.3838,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"shares","element":"transactionShares","label":"F5","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the restricted share units listed in Table II."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.835 to $10.910, inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":15571.486,"source":{"system":"sec-edgar","filing":"0001209191-21-017764","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919121017764/doc4.xml","form_type":"4"}},{"id":2810202,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":27437,"kind":"person","name":"O'Grady Brendan P.","position":1,"cik":"0001726533","reported_name":"O'Grady Brendan P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, North America Commercial"}}],"security":"Ordinary Shares","published_at":"2021-03-04T21:05:08.000Z","date":"2021-03-03","kind":"exercise","acquired":true,"shares":1166,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."}],"balance_after":16034.486,"source":{"system":"sec-edgar","filing":"0001209191-21-017764","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919121017764/doc4.xml","form_type":"4"}},{"id":2810201,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":27437,"kind":"person","name":"O'Grady Brendan P.","position":1,"cik":"0001726533","reported_name":"O'Grady Brendan P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, North America Commercial"}}],"security":"Ordinary Shares","published_at":"2021-03-04T21:05:08.000Z","date":"2021-03-02","kind":"sale","acquired":false,"shares":15085,"price":10.8453,"value":163601.3505,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.800 to $10.870, inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":14868.486,"source":{"system":"sec-edgar","filing":"0001209191-21-017764","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919121017764/doc4.xml","form_type":"4"}},{"id":2823343,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":27437,"kind":"person","name":"O'Grady Brendan P.","position":1,"cik":"0001726533","reported_name":"O'Grady Brendan P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, North America Commercial"}}],"security":"Restricted Share Units","published_at":"2021-03-02T21:07:44.000Z","date":"2021-02-28","kind":"exercise","acquired":false,"shares":24934,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"Restricted share units were granted on February 28, 2020 with 24,934 vesting on each of February 28, 2021, February 28, 2022 and February 28, 2023 and 24,937 vesting on February 28, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"Restricted share units were granted on February 28, 2020 with 24,934 vesting on each of February 28, 2021, February 28, 2022 and February 28, 2023 and 24,937 vesting on February 28, 2024."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":74805,"derivative":{"underlying":"Ordinary Shares","underlying_shares":24934},"source":{"system":"sec-edgar","filing":"0001209191-21-015852","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919121015852/doc4.xml","form_type":"4"}},{"id":2823342,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":27437,"kind":"person","name":"O'Grady Brendan P.","position":1,"cik":"0001726533","reported_name":"O'Grady Brendan P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, North America Commercial"}}],"security":"Ordinary Shares","published_at":"2021-03-02T21:07:44.000Z","date":"2021-03-01","kind":"sale","acquired":false,"shares":63278,"price":10.9256,"value":691350.1168,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"kind","element":"transactionCoding","label":"F3","text":"The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.905 to $10.980, inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":29953.486,"source":{"system":"sec-edgar","filing":"0001209191-21-015852","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919121015852/doc4.xml","form_type":"4"}},{"id":2823341,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":27437,"kind":"person","name":"O'Grady Brendan P.","position":1,"cik":"0001726533","reported_name":"O'Grady Brendan P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, North America Commercial"}}],"security":"Ordinary Shares","published_at":"2021-03-02T21:07:44.000Z","date":"2021-03-01","kind":"sale","acquired":false,"shares":9849,"price":10.8308,"value":106672.5492,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"kind","element":"transactionCoding","label":"F3","text":"The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"shares","element":"transactionShares","label":"F4","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the restricted share units listed in Table II."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.78 to $11.01, inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":93231.486,"source":{"system":"sec-edgar","filing":"0001209191-21-015852","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919121015852/doc4.xml","form_type":"4"}},{"id":2823340,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":27437,"kind":"person","name":"O'Grady Brendan P.","position":1,"cik":"0001726533","reported_name":"O'Grady Brendan P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, North America Commercial"}}],"security":"Ordinary Shares","published_at":"2021-03-02T21:07:44.000Z","date":"2021-02-28","kind":"exercise","acquired":true,"shares":24934,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."}],"balance_after":103080.486,"source":{"system":"sec-edgar","filing":"0001209191-21-015852","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919121015852/doc4.xml","form_type":"4"}},{"id":2867782,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":27437,"kind":"person","name":"O'Grady Brendan P.","position":1,"cik":"0001726533","reported_name":"O'Grady Brendan P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, North America Commercial"}}],"security":"Restricted Share Units","published_at":"2021-02-11T21:08:39.000Z","date":"2021-02-09","kind":"exercise","acquired":false,"shares":16120,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"Restricted share units were granted on February 9, 2018, with 16,120 vesting on each of February 9, 2020 and February 9, 2021 and 16,121 vesting on February 9, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F8","text":"Restricted share units were granted on February 9, 2018, with 16,120 vesting on each of February 9, 2020 and February 9, 2021 and 16,121 vesting on February 9, 2022."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":16121,"derivative":{"underlying":"Ordinary Shares","underlying_shares":16120},"source":{"system":"sec-edgar","filing":"0001209191-21-009639","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919121009639/doc4.xml","form_type":"4"}},{"id":2867781,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":27437,"kind":"person","name":"O'Grady Brendan P.","position":1,"cik":"0001726533","reported_name":"O'Grady Brendan P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, North America Commercial"}}],"security":"Ordinary Shares","published_at":"2021-02-11T21:08:39.000Z","date":"2021-02-09","kind":"sale","acquired":false,"shares":16720,"price":12.6945,"value":212252.04,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"kind","element":"transactionCoding","label":"F5","text":"The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"shares","element":"transactionShares","label":"F6","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the restricted share units listed in Table II."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.635 to $12.785, inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":78146.486,"source":{"system":"sec-edgar","filing":"0001209191-21-009639","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919121009639/doc4.xml","form_type":"4"}},{"id":2867780,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":27437,"kind":"person","name":"O'Grady Brendan P.","position":1,"cik":"0001726533","reported_name":"O'Grady Brendan P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, North America Commercial"}}],"security":"Ordinary Shares","published_at":"2021-02-11T21:08:39.000Z","date":"2021-02-09","kind":"sale","acquired":false,"shares":3974,"price":12.6945,"value":50447.943,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"kind","element":"transactionCoding","label":"F5","text":"The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"shares","element":"transactionShares","label":"F6","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the restricted share units listed in Table II."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.635 to $12.785, inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":94866.486,"source":{"system":"sec-edgar","filing":"0001209191-21-009639","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919121009639/doc4.xml","form_type":"4"}},{"id":2867779,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":27437,"kind":"person","name":"O'Grady Brendan P.","position":1,"cik":"0001726533","reported_name":"O'Grady Brendan P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, North America Commercial"}}],"security":"Ordinary Shares","published_at":"2021-02-11T21:08:39.000Z","date":"2021-02-09","kind":"grant","acquired":true,"shares":67852,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"kind","element":"transactionCoding","label":"F3","text":"Represents ordinary shares received upon satisfaction of performance- and time-based vesting criteria of performance share units."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Each performance share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources\nand Compensation Committee, the cash value of one ordinary share."}],"balance_after":98840.486,"source":{"system":"sec-edgar","filing":"0001209191-21-009639","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919121009639/doc4.xml","form_type":"4"}},{"id":2867778,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":27437,"kind":"person","name":"O'Grady Brendan P.","position":1,"cik":"0001726533","reported_name":"O'Grady Brendan P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, North America Commercial"}}],"security":"Ordinary Shares","published_at":"2021-02-11T21:08:39.000Z","date":"2021-02-09","kind":"exercise","acquired":true,"shares":16120,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."}],"balance_after":30988.486,"source":{"system":"sec-edgar","filing":"0001209191-21-009639","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919121009639/doc4.xml","form_type":"4"}},{"id":3201336,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":27437,"kind":"person","name":"O'Grady Brendan P.","position":1,"cik":"0001726533","reported_name":"O'Grady Brendan P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, North America Commercial"}}],"security":"Restricted Share Units","published_at":"2020-03-19T11:37:42.000Z","date":"2020-03-17","kind":"exercise","acquired":false,"shares":1179,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Restricted share units were granted on March 17, 2016, with 1,179 vesting on each of March 17, 2018, March 17, 2019 and March 17, 2020."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"Restricted share units were granted on March 17, 2016, with 1,179 vesting on each of March 17, 2018, March 17, 2019 and March 17, 2020."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":0,"derivative":{"underlying":"Ordinary Shares","underlying_shares":1179},"source":{"system":"sec-edgar","filing":"0001209191-20-020165","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919120020165/doc4.xml","form_type":"4"}},{"id":3201335,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":27437,"kind":"person","name":"O'Grady Brendan P.","position":1,"cik":"0001726533","reported_name":"O'Grady Brendan P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, North America Commercial"}}],"security":"Ordinary Shares","published_at":"2020-03-19T11:37:42.000Z","date":"2020-03-17","kind":"sale","acquired":false,"shares":470,"price":7.1635,"value":3366.845,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"kind","element":"transactionCoding","label":"F3","text":"The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"shares","element":"transactionShares","label":"F4","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the restricted share units listed in Table II."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.1600 to $7.1850, inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":14868.486,"source":{"system":"sec-edgar","filing":"0001209191-20-020165","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919120020165/doc4.xml","form_type":"4"}},{"id":3201334,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":27437,"kind":"person","name":"O'Grady Brendan P.","position":1,"cik":"0001726533","reported_name":"O'Grady Brendan P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, North America Commercial"}}],"security":"Ordinary Shares","published_at":"2020-03-19T11:37:42.000Z","date":"2020-03-17","kind":"exercise","acquired":true,"shares":1179,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."}],"balance_after":15338.486,"source":{"system":"sec-edgar","filing":"0001209191-20-020165","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919120020165/doc4.xml","form_type":"4"}},{"id":3225620,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":27437,"kind":"person","name":"O'Grady Brendan P.","position":1,"cik":"0001726533","reported_name":"O'Grady Brendan P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, North America Commercial"}}],"security":"Restricted Share Units","published_at":"2020-03-05T13:13:24.000Z","date":"2020-03-03","kind":"exercise","acquired":false,"shares":1166,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Restricted share units were granted on March 3, 2017, with 1,166 vesting on each of March 3, 2018, March 3, 2019, March 3, 2020 and March 3, 2021."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"Restricted share units were granted on March 3, 2017, with 1,166 vesting on each of March 3, 2018, March 3, 2019, March 3, 2020 and March 3, 2021."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":1166,"derivative":{"underlying":"Ordinary Shares","underlying_shares":1166},"source":{"system":"sec-edgar","filing":"0001209191-20-016461","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919120016461/doc4.xml","form_type":"4"}},{"id":3225619,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":27437,"kind":"person","name":"O'Grady Brendan P.","position":1,"cik":"0001726533","reported_name":"O'Grady Brendan P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, North America Commercial"}}],"security":"Ordinary Shares","published_at":"2020-03-05T13:13:24.000Z","date":"2020-03-03","kind":"sale","acquired":false,"shares":463,"price":11.3658,"value":5262.3654,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"kind","element":"transactionCoding","label":"F3","text":"The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"shares","element":"transactionShares","label":"F4","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the restricted share units listed in Table II."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.8900 to $11.7400, inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":14159.486,"source":{"system":"sec-edgar","filing":"0001209191-20-016461","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919120016461/doc4.xml","form_type":"4"}},{"id":3225618,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":27437,"kind":"person","name":"O'Grady Brendan P.","position":1,"cik":"0001726533","reported_name":"O'Grady Brendan P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, North America Commercial"}}],"security":"Ordinary Shares","published_at":"2020-03-05T13:13:24.000Z","date":"2020-03-03","kind":"exercise","acquired":true,"shares":1166,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."}],"balance_after":14622.486,"source":{"system":"sec-edgar","filing":"0001209191-20-016461","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919120016461/doc4.xml","form_type":"4"}},{"id":3235429,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":27437,"kind":"person","name":"O'Grady Brendan P.","position":1,"cik":"0001726533","reported_name":"O'Grady Brendan P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, North America Commercial"}}],"security":"Restricted Share Units","published_at":"2020-03-03T12:17:51.000Z","date":"2020-02-28","kind":"grant","acquired":true,"shares":99739,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Restricted share units were granted on February 28, 2020 with 24,934 vesting on each of February 28, 2021, February 28, 2022 and February 28, 2023 and 24,937 vesting on February 28, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Restricted share units were granted on February 28, 2020 with 24,934 vesting on each of February 28, 2021, February 28, 2022 and February 28, 2023 and 24,937 vesting on February 28, 2024."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F3","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":99739,"derivative":{"underlying":"Ordinary Shares","underlying_shares":99739},"source":{"system":"sec-edgar","filing":"0001209191-20-014853","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919120014853/doc4.xml","form_type":"4"}},{"id":3280660,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":27437,"kind":"person","name":"O'Grady Brendan P.","position":1,"cik":"0001726533","reported_name":"O'Grady Brendan P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, North America Commercial"}}],"security":"Restricted Share Units","published_at":"2020-02-11T12:02:23.000Z","date":"2020-02-09","kind":"exercise","acquired":false,"shares":16120,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Restricted share units were granted on February 9, 2018, with 16,120 vesting on each of February 9, 2020 and February 9, 2021 and 16,121 vesting on February 9, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Restricted share units were granted on February 9, 2018, with 16,120 vesting on each of February 9, 2020 and February 9, 2021 and 16,121 vesting on February 9, 2022."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":32241,"derivative":{"underlying":"Ordinary Shares","underlying_shares":16120},"source":{"system":"sec-edgar","filing":"0001209191-20-008166","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919120008166/doc4.xml","form_type":"4"}},{"id":3280659,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":27437,"kind":"person","name":"O'Grady Brendan P.","position":1,"cik":"0001726533","reported_name":"O'Grady Brendan P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, North America Commercial"}}],"security":"Ordinary Shares","published_at":"2020-02-11T12:02:23.000Z","date":"2020-02-10","kind":"sale","acquired":false,"shares":4799,"price":12.27,"value":58883.73,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"kind","element":"transactionCoding","label":"F3","text":"The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"shares","element":"transactionShares","label":"F4","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the restricted share units listed in Table II."}],"balance_after":13456.486,"source":{"system":"sec-edgar","filing":"0001209191-20-008166","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919120008166/doc4.xml","form_type":"4"}},{"id":3280658,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":27437,"kind":"person","name":"O'Grady Brendan P.","position":1,"cik":"0001726533","reported_name":"O'Grady Brendan P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, North America Commercial"}}],"security":"Ordinary Shares","published_at":"2020-02-11T12:02:23.000Z","date":"2020-02-09","kind":"exercise","acquired":true,"shares":16120,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."}],"balance_after":18255.486,"source":{"system":"sec-edgar","filing":"0001209191-20-008166","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919120008166/doc4.xml","form_type":"4"}},{"id":3409359,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":27437,"kind":"person","name":"O'Grady Brendan P.","position":1,"cik":"0001726533","reported_name":"O'Grady Brendan P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, North America Commercial"}}],"security":"Restricted Share Units","published_at":"2019-09-20T11:19:58.000Z","date":"2019-09-18","kind":"exercise","acquired":false,"shares":1241,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Restricted share units were granted on September 18, 2017, with 1,241 vesting on each of September 18, 2018 and September 18, 2019."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Restricted share units were granted on September 18, 2017, with 1,241 vesting on each of September 18, 2018 and September 18, 2019."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":0,"derivative":{"underlying":"Ordinary Shares","underlying_shares":1241},"source":{"system":"sec-edgar","filing":"0001209191-19-050266","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919119050266/doc4.xml","form_type":"4"}},{"id":3409358,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":27437,"kind":"person","name":"O'Grady Brendan P.","position":1,"cik":"0001726533","reported_name":"O'Grady Brendan P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, North America Commercial"}}],"security":"Ordinary Shares","published_at":"2019-09-20T11:19:58.000Z","date":"2019-09-18","kind":"sale","acquired":false,"shares":494,"price":7.8313,"value":3868.6622,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"shares","element":"transactionShares","label":"F3","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the restricted share units listed in Table II."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.82 to $7.835, inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":2135.486,"source":{"system":"sec-edgar","filing":"0001209191-19-050266","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919119050266/doc4.xml","form_type":"4"}},{"id":3409357,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":27437,"kind":"person","name":"O'Grady Brendan P.","position":1,"cik":"0001726533","reported_name":"O'Grady Brendan P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, North America Commercial"}}],"security":"Ordinary Shares","published_at":"2019-09-20T11:19:58.000Z","date":"2019-09-18","kind":"exercise","acquired":true,"shares":1241,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."}],"balance_after":2629.486,"source":{"system":"sec-edgar","filing":"0001209191-19-050266","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919119050266/doc4.xml","form_type":"4"}},{"id":3589274,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":27437,"kind":"person","name":"O'Grady Brendan P.","position":1,"cik":"0001726533","reported_name":"O'Grady Brendan P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, North America Commercial"}}],"security":"Restricted Share Units","published_at":"2019-03-19T12:29:17.000Z","date":"2019-03-17","kind":"exercise","acquired":false,"shares":1179,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Restricted share units were granted on March 17, 2016, with 1,179 vesting on each of March 17, 2018, March 17, 2019 and March 17, 2020."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Restricted share units were granted on March 17, 2016, with 1,179 vesting on each of March 17, 2018, March 17, 2019 and March 17, 2020."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":1179,"derivative":{"underlying":"Ordinary Shares","underlying_shares":1179},"source":{"system":"sec-edgar","filing":"0001209191-19-020163","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919119020163/doc4.xml","form_type":"4"}},{"id":3589273,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":27437,"kind":"person","name":"O'Grady Brendan P.","position":1,"cik":"0001726533","reported_name":"O'Grady Brendan P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, North America Commercial"}}],"security":"Ordinary Shares","published_at":"2019-03-19T12:29:17.000Z","date":"2019-03-18","kind":"sale","acquired":false,"shares":1179,"price":16.6251,"value":19600.9929,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.5800 to $16.6800, inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":1388.486,"source":{"system":"sec-edgar","filing":"0001209191-19-020163","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919119020163/doc4.xml","form_type":"4"}},{"id":3589272,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":27437,"kind":"person","name":"O'Grady Brendan P.","position":1,"cik":"0001726533","reported_name":"O'Grady Brendan P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, North America Commercial"}}],"security":"Ordinary Shares","published_at":"2019-03-19T12:29:17.000Z","date":"2019-03-17","kind":"exercise","acquired":true,"shares":1179,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."}],"balance_after":2567.486,"source":{"system":"sec-edgar","filing":"0001209191-19-020163","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919119020163/doc4.xml","form_type":"4"}},{"id":3596259,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":27437,"kind":"person","name":"O'Grady Brendan P.","position":1,"cik":"0001726533","reported_name":"O'Grady Brendan P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, North America Commercial"}}],"security":"Restricted Share Units","published_at":"2019-03-14T11:41:50.000Z","date":"2019-03-12","kind":"exercise","acquired":false,"shares":738,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Restricted share units were granted on March 12, 2015, with 738 vesting on each of March 12, 2018 and March 12, 2019."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Restricted share units were granted on March 12, 2015, with 738 vesting on each of March 12, 2018 and March 12, 2019."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":0,"derivative":{"underlying":"Ordinary Shares","underlying_shares":738},"source":{"system":"sec-edgar","filing":"0001209191-19-019332","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919119019332/doc4.xml","form_type":"4"}},{"id":3596258,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":27437,"kind":"person","name":"O'Grady Brendan P.","position":1,"cik":"0001726533","reported_name":"O'Grady Brendan P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, North America Commercial"}}],"security":"Ordinary Shares","published_at":"2019-03-14T11:41:50.000Z","date":"2019-03-12","kind":"sale","acquired":false,"shares":738,"price":15.6749,"value":11568.0762,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.6600 to $15.6911, inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":1388.486,"source":{"system":"sec-edgar","filing":"0001209191-19-019332","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919119019332/doc4.xml","form_type":"4"}},{"id":3596257,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":27437,"kind":"person","name":"O'Grady Brendan P.","position":1,"cik":"0001726533","reported_name":"O'Grady Brendan P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, North America Commercial"}}],"security":"Ordinary Shares","published_at":"2019-03-14T11:41:50.000Z","date":"2019-03-12","kind":"exercise","acquired":true,"shares":738,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."}],"balance_after":2126.486,"source":{"system":"sec-edgar","filing":"0001209191-19-019332","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919119019332/doc4.xml","form_type":"4"}},{"id":3609905,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":27437,"kind":"person","name":"O'Grady Brendan P.","position":1,"cik":"0001726533","reported_name":"O'Grady Brendan P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, North America Commercial"}}],"security":"Restricted Share Units","published_at":"2019-03-06T12:24:05.000Z","date":"2019-03-04","kind":"grant","acquired":true,"shares":56716,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Restricted share units were granted on March 4, 2019, with 18,905 vesting on each of March 4, 2021 and March 4, 2022 and 18,906 vesting on March 4, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Restricted share units were granted on March 4, 2019, with 18,905 vesting on each of March 4, 2021 and March 4, 2022 and 18,906 vesting on March 4, 2023."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F3","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":56716,"derivative":{"underlying":"Ordinary Shares","underlying_shares":56716},"source":{"system":"sec-edgar","filing":"0001209191-19-017234","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919119017234/doc4.xml","form_type":"4"}},{"id":3616193,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":27437,"kind":"person","name":"O'Grady Brendan P.","position":1,"cik":"0001726533","reported_name":"O'Grady Brendan P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, North America Commercial"}}],"security":"Restricted Share Units","published_at":"2019-03-05T12:36:03.000Z","date":"2019-03-03","kind":"exercise","acquired":false,"shares":1166,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Restricted share units were granted on March 3, 2017, with 1,166 vesting on each of March 3, 2018, March 3, 2019, March 3, 2020 and March 3, 2021."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Restricted share units were granted on March 3, 2017, with 1,166 vesting on each of March 3, 2018, March 3, 2019, March 3, 2020 and March 3, 2021."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":2332,"derivative":{"underlying":"Ordinary Shares","underlying_shares":1166},"source":{"system":"sec-edgar","filing":"0001209191-19-016093","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919119016093/doc4.xml","form_type":"4"}},{"id":3616192,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":27437,"kind":"person","name":"O'Grady Brendan P.","position":1,"cik":"0001726533","reported_name":"O'Grady Brendan P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, North America Commercial"}}],"security":"Ordinary Shares","published_at":"2019-03-05T12:36:03.000Z","date":"2019-03-04","kind":"sale","acquired":false,"shares":1166,"price":16.8833,"value":19685.9278,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.755 to $17.130, inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":1388.486,"source":{"system":"sec-edgar","filing":"0001209191-19-016093","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919119016093/doc4.xml","form_type":"4"}},{"id":3616191,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":27437,"kind":"person","name":"O'Grady Brendan P.","position":1,"cik":"0001726533","reported_name":"O'Grady Brendan P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, North America Commercial"}}],"security":"Ordinary Shares","published_at":"2019-03-05T12:36:03.000Z","date":"2019-03-03","kind":"exercise","acquired":true,"shares":1166,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."}],"balance_after":2554.486,"source":{"system":"sec-edgar","filing":"0001209191-19-016093","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919119016093/doc4.xml","form_type":"4"}},{"id":3811102,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":27437,"kind":"person","name":"O'Grady Brendan P.","position":1,"cik":"0001726533","reported_name":"O'Grady Brendan P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, North America Commercial"}}],"security":"Restricted Share Units","published_at":"2018-09-20T20:10:34.000Z","date":"2018-09-18","kind":"exercise","acquired":false,"shares":1241,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Restricted share units were granted on September 18, 2017, with 1,241 vesting on each of September 18, 2018 and September 18, 2019."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Restricted share units were granted on September 18, 2017, with 1,241 vesting on each of September 18, 2018 and September 18, 2019."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":1241,"derivative":{"underlying":"Ordinary Shares","underlying_shares":1241},"source":{"system":"sec-edgar","filing":"0001209191-18-051780","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919118051780/doc4.xml","form_type":"4"}},{"id":3811101,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":27437,"kind":"person","name":"O'Grady Brendan P.","position":1,"cik":"0001726533","reported_name":"O'Grady Brendan P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, North America Commercial"}}],"security":"Ordinary Shares","published_at":"2018-09-20T20:10:34.000Z","date":"2018-09-18","kind":"sale","acquired":false,"shares":1241,"price":23.707,"value":29420.387,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.640 to $23.735, inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":1388.486,"source":{"system":"sec-edgar","filing":"0001209191-18-051780","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919118051780/doc4.xml","form_type":"4"}},{"id":3811100,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":27437,"kind":"person","name":"O'Grady Brendan P.","position":1,"cik":"0001726533","reported_name":"O'Grady Brendan P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, North America Commercial"}}],"security":"Ordinary Shares","published_at":"2018-09-20T20:10:34.000Z","date":"2018-09-18","kind":"exercise","acquired":true,"shares":1241,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."}],"balance_after":2629.486,"source":{"system":"sec-edgar","filing":"0001209191-18-051780","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919118051780/doc4.xml","form_type":"4"}},{"id":3988473,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":27437,"kind":"person","name":"O'Grady Brendan P.","position":1,"cik":"0001726533","reported_name":"O'Grady Brendan P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, North America Commercial"}}],"security":"Restricted Share Units","published_at":"2018-03-20T20:13:01.000Z","date":"2018-03-17","kind":"exercise","acquired":false,"shares":1179,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Restricted share units were granted on March 17, 2016, with 1,179 vesting on each of March 17, 2018, March 17, 2019 and March 17, 2020."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Restricted share units were granted on March 17, 2016, with 1,179 vesting on each of March 17, 2018, March 17, 2019 and March 17, 2020."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":2358,"derivative":{"underlying":"Ordinary Shares","underlying_shares":1179},"source":{"system":"sec-edgar","filing":"0001209191-18-020864","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919118020864/doc4.xml","form_type":"4"}},{"id":3988472,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":27437,"kind":"person","name":"O'Grady Brendan P.","position":1,"cik":"0001726533","reported_name":"O'Grady Brendan P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, North America Commercial"}}],"security":"Ordinary Shares","published_at":"2018-03-20T20:13:01.000Z","date":"2018-03-19","kind":"sale","acquired":false,"shares":1179,"price":17.878,"value":21078.162,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $17.83 to $17.925, inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":1388.486,"source":{"system":"sec-edgar","filing":"0001209191-18-020864","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919118020864/doc4.xml","form_type":"4"}},{"id":3988471,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":27437,"kind":"person","name":"O'Grady Brendan P.","position":1,"cik":"0001726533","reported_name":"O'Grady Brendan P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, North America Commercial"}}],"security":"Ordinary Shares","published_at":"2018-03-20T20:13:01.000Z","date":"2018-03-17","kind":"exercise","acquired":true,"shares":1179,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."}],"balance_after":2567.486,"source":{"system":"sec-edgar","filing":"0001209191-18-020864","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919118020864/doc4.xml","form_type":"4"}},{"id":3997152,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":27437,"kind":"person","name":"O'Grady Brendan P.","position":1,"cik":"0001726533","reported_name":"O'Grady Brendan P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, North America Commercial"}}],"security":"Restricted Share Units","published_at":"2018-03-14T20:34:01.000Z","date":"2018-03-12","kind":"exercise","acquired":false,"shares":738,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Restricted share units were granted on March 12, 2015, with 738 vesting on each of March 12, 2018 and March 12, 2019."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Restricted share units were granted on March 12, 2015, with 738 vesting on each of March 12, 2018 and March 12, 2019."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":738,"derivative":{"underlying":"Ordinary Shares","underlying_shares":738},"source":{"system":"sec-edgar","filing":"0001209191-18-019567","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919118019567/doc4.xml","form_type":"4"}},{"id":3997151,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":27437,"kind":"person","name":"O'Grady Brendan P.","position":1,"cik":"0001726533","reported_name":"O'Grady Brendan P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, North America Commercial"}}],"security":"Ordinary Shares","published_at":"2018-03-14T20:34:01.000Z","date":"2018-03-12","kind":"sale","acquired":false,"shares":738,"price":19.489,"value":14382.882,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.46 to $19.50, inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":1388.486,"source":{"system":"sec-edgar","filing":"0001209191-18-019567","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919118019567/doc4.xml","form_type":"4"}},{"id":3997150,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":27437,"kind":"person","name":"O'Grady Brendan P.","position":1,"cik":"0001726533","reported_name":"O'Grady Brendan P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, North America Commercial"}}],"security":"Ordinary Shares","published_at":"2018-03-14T20:34:01.000Z","date":"2018-03-12","kind":"exercise","acquired":true,"shares":738,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."}],"balance_after":2126.486,"source":{"system":"sec-edgar","filing":"0001209191-18-019567","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919118019567/doc4.xml","form_type":"4"}},{"id":4012719,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":27437,"kind":"person","name":"O'Grady Brendan P.","position":1,"cik":"0001726533","reported_name":"O'Grady Brendan P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, North America Commercial"}}],"security":"Restricted Share Units","published_at":"2018-03-06T21:20:01.000Z","date":"2018-03-03","kind":"exercise","acquired":false,"shares":1166,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Restricted share units were granted on March 3, 2017, with 1,166 vesting on each of March 3, 2018, March 3, 2019, March 3, 2020 and March 3, 2021."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Restricted share units were granted on March 3, 2017, with 1,166 vesting on each of March 3, 2018, March 3, 2019, March 3, 2020 and March 3, 2021."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":3498,"derivative":{"underlying":"Ordinary Shares","underlying_shares":1166},"source":{"system":"sec-edgar","filing":"0001209191-18-017230","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919118017230/doc4.xml","form_type":"4"}},{"id":4012718,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":27437,"kind":"person","name":"O'Grady Brendan P.","position":1,"cik":"0001726533","reported_name":"O'Grady Brendan P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, North America Commercial"}}],"security":"Ordinary Shares","published_at":"2018-03-06T21:20:01.000Z","date":"2018-03-05","kind":"sale","acquired":false,"shares":705,"price":19.38,"value":13662.9,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":1388.486,"source":{"system":"sec-edgar","filing":"0001209191-18-017230","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919118017230/doc4.xml","form_type":"4"}},{"id":4012717,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":27437,"kind":"person","name":"O'Grady Brendan P.","position":1,"cik":"0001726533","reported_name":"O'Grady Brendan P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, North America Commercial"}}],"security":"Ordinary Shares","published_at":"2018-03-06T21:20:01.000Z","date":"2018-03-05","kind":"tax_withholding","acquired":false,"shares":461,"price":19.38,"value":8934.18,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":2093.486,"source":{"system":"sec-edgar","filing":"0001209191-18-017230","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919118017230/doc4.xml","form_type":"4"}},{"id":4012716,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":27437,"kind":"person","name":"O'Grady Brendan P.","position":1,"cik":"0001726533","reported_name":"O'Grady Brendan P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, North America Commercial"}}],"security":"Ordinary Shares","published_at":"2018-03-06T21:20:01.000Z","date":"2018-03-03","kind":"exercise","acquired":true,"shares":1166,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."}],"balance_after":2554.486,"source":{"system":"sec-edgar","filing":"0001209191-18-017230","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919118017230/doc4.xml","form_type":"4"}},{"id":4067055,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":27437,"kind":"person","name":"O'Grady Brendan P.","position":1,"cik":"0001726533","reported_name":"O'Grady Brendan P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, North America Commercial"}}],"security":"Restricted Share Units","published_at":"2018-02-12T21:25:03.000Z","date":"2018-02-09","kind":"grant","acquired":true,"shares":48361,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Restricted share units were granted on February 9, 2018, with 16,120 vesting on each of February 9, 2020 and February 9, 2021 and 16,121 vesting on February 9, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Restricted share units were granted on February 9, 2018, with 16,120 vesting on each of February 9, 2020 and February 9, 2021 and 16,121 vesting on February 9, 2022."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F2","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":48361,"derivative":{"underlying":"Ordinary Shares","underlying_shares":48361},"source":{"system":"sec-edgar","filing":"0001209191-18-009201","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919118009201/doc4.xml","form_type":"4"}},{"id":4067054,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":27437,"kind":"person","name":"O'Grady Brendan P.","position":1,"cik":"0001726533","reported_name":"O'Grady Brendan P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, North America Commercial"}}],"security":"Stock Options (right to buy)","published_at":"2018-02-12T21:25:03.000Z","date":"2018-02-09","kind":"grant","acquired":true,"shares":123288,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Stock options were granted on February 9, 2018, with 41,096 vesting on each of February 9, 2020, February 9, 2021 and February 9, 2022."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F2","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":123288,"derivative":{"exercise_price":18.61,"expiration_date":"2028-02-08","underlying":"Ordinary Shares","underlying_shares":123288},"source":{"system":"sec-edgar","filing":"0001209191-18-009201","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919118009201/doc4.xml","form_type":"4"}}]}